Furthermore, our study uniquely identified a statistically significant relationship between patients’ FGS scores and kallistatin levels in PCOS groups, indicating that this finding could be promising for monitoring the clinical manifestations of PCOS. Here, SERPINA4 is linked to polycystic ovary syndrome.